Vietnam Point of Care Diagnostics Market Report 2025, Share, Growth, Trends and Forecast Till 2033

Market Overview

The Vietnam Point of Care Diagnostics market size was USD 212.4 Million in 2024 and is expected to reach USD 444.2 Million by 2033. The market is projected to grow at a CAGR of 8.54% during the forecast period 2025-2033. Growth is driven by increasing prevalence of infectious diseases, advancements in diagnostic technologies, and rising demand for rapid and accurate diagnostics, which are pivotal in emergency care and decentralized healthcare settings.

Sample Request Link: https://www.imarcgroup.com/vietnam-point-of-care-diagnostics-market/requestsample

Study Assumption Years

Base Year: 2024
Historical Year/Period: 2019-2024
Forecast Year/Period: 2025-2033

Vietnam Point of Care Diagnostics Market Key Takeaways

Current Market Size: USD 212.4 Million in 2024
CAGR: 8.54% (2025-2033)
Forecast Period: 2025-2033
The market is propelled by the rise in infectious diseases and growing demand for personalized medicine and rapid diagnostic results.
Technological advancements such as biosensors, microfluidics, and molecular diagnostics continue to enhance diagnostic accuracy and portability.
Expansion of healthcare services into rural and remote areas fuels demand for portable, user-friendly diagnostics.
Government initiatives aimed at improving healthcare infrastructure and spending also support market growth.
The COVID-19 pandemic has accelerated adoption of point-of-care testing platforms for effective public health management.

Market Growth Factors

More infectious diseases create a need within Vietnam for point of care diagnostic tests. Doctors require reliable point of care diagnostic tests to promptly diagnose infectious diseases, thereby ensuring they treat when necessary in a timely way and control the disease's spread. Pathogens and viruses need control in hospitals, clinics, and ambulances.

Technological advancements in lateral flow assays, biosensors, microfluidics, and molecular diagnostics have improved the efficiency, sensitivity, and portability of point-of-care testing devices, supporting market growth. These advance and meet the needs of the healthcare community through rapid and accurate diagnostic testing in resource-constrained or far-off settings. Customary laboratory testing may not be feasible in these settings.

Government started initiatives for improvement in quality and accessibility regarding healthcare in Vietnam. These initiatives drove point-of-care diagnostics through an increase regarding healthcare spending. They improved healthcare infrastructure with government policies encouraging technology and integration into the healthcare system. Health services moved to rural areas of Vietnam. This change showed a need for diagnostic test kits. Individuals without medical training can use these kits at the point of care.

Request Customization: https://www.imarcgroup.com/request?type=report&id=19570&flag=E

Market Segmentation

Product Type Insights:

Blood-Glucose Monitoring Kit: Devices for monitoring blood glucose levels, crucial for diabetes management.
Cardio-Metabolic Monitoring Kit: Kits used to monitor cardiovascular and metabolic health parameters.
Pregnancy and Fertility Testing Kit: Diagnostics for pregnancy detection and fertility assessment.
Infectious Disease Testing Kit: Kits designed for on-site detection of infectious pathogens.
Cholesterol Test Strip: Strips used to measure cholesterol levels quickly.
Hematology Testing Kit: Kits used for blood component analysis.
Others: Additional diagnostic kits not classified in the above types.

Platform Insights:

Lateral Flow Assays: Simple rapid tests typically involving strip-based assays.
Dipsticks: Diagnostic strips offering quick results.
Microfluidics: Devices utilizing fluid dynamics for precise diagnostics.
Molecular Diagnostics: Techniques involving molecular-level analysis for detection.
Immunoassays: Tests based on antigen-antibody reactions.

Prescription Mode Insights:

Prescription-Based Testing: Diagnostics requiring a medical prescription for use.
OTC Testing: Over-the-counter testing kits available without prescription.

End User Insights:

Professional Diagnostic Centers: Healthcare facilities offering diagnostic services.
Home Care: Diagnostics intended for patient use at home.
Research Laboratories: Labs conducting diagnostic research.
Others: Additional end-user categories not specified above.

Regional Insights:

Northern Vietnam
Central Vietnam
Southern Vietnam

Regional Insights

Northern Vietnam, Central Vietnam, and Southern Vietnam constitute the major regional markets within the country. The report does not provide explicit comparative statistics or dominant region data. Overall demand across these regions is influenced by expanding healthcare services, economic development, and government healthcare initiatives.

Key Players

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Customization Note

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302

About Us

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.